510(k) Report

510(k) · Cleared

Cleared

RX-1 Rhythm Express Remote Cardiac Monitoring System

K200833510(k) TraditionalCleared Sep 2, 2020156-day reviewClass II21 CFR 870.2800

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

VivaQuant, Inc. · MLO Electrocardiograph, Ambulatory, With Analysis Algorithm

Cleared on Sep 2, 2020 as substantially equivalent to K183704 (VivaQuant, Inc., 2019) and 1 other predicate after a 156-day review. Its family tree reaches back 8 generations to 1988. 1 later device descends from it.

Decided
Sep 2, 2020
Review
156 days
Class
Class II
Product code
MLO
Recalls
None
Predicates
2

Its longest line of descent runs back 8 generations to K882803 (1988). 30 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 8 generations backK882803 ET HI-Flow Soft Tip/ET HI-Flow/Enhanced Torque STAdvanced Cardiovascular Systems, Inc. · 1988
  2. 7 generations backK012241 Cardionet Ambulatory Ecg Monitor with Arrhythmia Detection, Model…Cardionet, Inc. · 2002
  3. 6 generations backK052240 Cardionet Ambulatory Ecg Monitor with Arrhythmia Detection, Model 1002Cardionet, Inc. · 2005
  4. 5 generations backK063222 Cardionet Ambulatory Ecg Monitor with Arrhythmia Detection, Model…Cardionet, Inc. · 2006
  5. 4 generations backK072558 Cardionet Ambulatory Ecg Monitor with Arrhythmia Detection, Model…Cardionet, Inc. · 2007
  6. 3 generations backK112921 Medicalgorithmics Unified Arrhythmia Diagnostic SystemMedicalgorithmics S.A. · 2012
  7. 2 generations backK124060 Medical Gorithmics Unified Arrhythmia Diagnostic SystemMedicalgorithmics S.A. · 2013
  8. 1 generation backK152550 Medicalgorithmics Unified Arrhythmia Diagnosic SystemMedicalgorithmics S.A. · 2015
  9. This deviceK200833 RX-1 Rhythm Express Remote Cardiac Monitoring SystemVivaQuant, Inc. · 2020
  10. Descendant · cites it directly · 0 of its ownK241179 Rhythm Express Remote Cardiac Monitoring System (RX-1 mini)VivaQuant, Inc. · 2025

Most influential descendants

Showing 1 of 1 · See all
  • K241179Rhythm Express Remote Cardiac Monitoring System (RX-1 mini)VivaQuant, Inc. · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K882803ET HI-Flow Soft Tip/ET HI-Flow/Enhanced Torque STAdvanced Cardiovascular Systems, Inc.1988—
−7K012241Cardionet Ambulatory Ecg Monitor with Arrhythmia Detection, Model CN1001Cardionet, Inc.2002—
−6K052240Cardionet Ambulatory Ecg Monitor with Arrhythmia Detection, Model 1002Cardionet, Inc.2005—
−5K063222Cardionet Ambulatory Ecg Monitor with Arrhythmia Detection, Model CN1004Cardionet, Inc.2006—
−4K072558Cardionet Ambulatory Ecg Monitor with Arrhythmia Detection, Model CN1005Cardionet, Inc.2007—
−3K112921Medicalgorithmics Unified Arrhythmia Diagnostic SystemMedicalgorithmics S.A.2012—
−2K124060Medical Gorithmics Unified Arrhythmia Diagnostic SystemMedicalgorithmics S.A.2013—
−1K152550Medicalgorithmics Unified Arrhythmia Diagnosic SystemMedicalgorithmics S.A.2015—
0 (this device)K200833RX-1 Rhythm Express Remote Cardiac Monitoring SystemVivaQuant, Inc.2020—
+1K241179Rhythm Express Remote Cardiac Monitoring System (RX-1 mini)VivaQuant, Inc.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199620
199720
199910
200020
200130
200210
200310
200410
200530
200610
200820
201310
201410
201910

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
FIG. 1 — Lineage of K200833, 1988–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MLO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MLO device

  1. #1 K261580 ZBPro Diagnostic (Version 2.0)score 13.8 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K183704RX-1 Rhythm Express Remote Cardiac Monitoring System
Summary page 4
…lent in intended use and similar technological characteristics to the following devices: RX-1 Rhythm Express Remote Cardiac Monitoring System cleared under K183704, and PocketECG III - Medicalgorithmics Unified Arrhythmia Diagnostic System, cleared under K152550.…
VivaQuant, Inc.2019—
*K152550Medicalgorithmics Unified Arrhythmia Diagnosic System
Summary page 4
…m Express Remote Cardiac Monitoring System cleared under K183704, and PocketECG III - Medicalgorithmics Unified Arrhythmia Diagnostic System, cleared under K152550. Page 1 of 9…
Medicalgorithmics S.A.2015—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K241179Rhythm Express Remote Cardiac Monitoring System (RX-1 mini)VivaQuant, Inc.20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 32 years and passes through 4 companies; a new generation was cleared every 3.7 years on median.
  • None of the 30 ancestors has a recall.
  • Of its descendants, K241179 (VivaQuant, Inc., 2025) has gone furthest, with 0 descendants of its own.

How does its category compare?

All MLO devices

MLO Electrocardiograph, Ambulatory, With Analysis Algorithm: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · MLO

1in 2025

2007: 12010: 12011: 32012: 12013: 22014: 12018: 12020: 22024: 12025: 12026 (partial year): 1
2007high 3 (2011) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MLO

238in 2011

2011: 238 days median
2007high 238 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MLO

2in 2024

2024: 2
2007high 2 (2024) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MLO

4in 2025

2009: 52010: 12011: 12014: 12017: 12018: 12019: 12021: 12022: 12023: 12024: 22025: 4
2007high 5 (2009) · low 0 (2007)2025

MAUDE reports naming product code MLO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20090—05
20101—01
2011323801
20121—00
20132—00
20141—01
20150—00
20160—00
20170—01
20181—01
20190—01
20202—00
20210—01
20220—01
20230—01
20241—22
20251—04
20261—0—

What is it indicated for?

The Rhythm Express remote cardiac monitoring system is intended for use by patients greater than 10 kg who either have or are at risk of having cardiac disease and those that demonstrate intermittent symptoms indicative of cardiac disease and require cardiac monitoring on a continuing basis. The device continuously records ECG data and upon detection by an ECG analysis algorithm or manually initiated by the patient, automatically delivers the recorded…

Read the full statement (174 words)

The Rhythm Express remote cardiac monitoring system is intended for use by patients greater than 10 kg who either have or are at risk of having cardiac disease and those that demonstrate intermittent symptoms indicative of cardiac disease and require cardiac monitoring on a continuing basis. The device continuously records ECG data and upon detection by an ECG analysis algorithm or manually initiated by the patient, automatically delivers the recorded cardiac activity to the server where it is presented for review by a medical professional.

The data received from the Rhythm Express device can be used by another device for arrhythmia analysis, reporting and signal measurements. The Rhythm Express device is not intended to sound any alarms.

The device does not deliver any therapy, administer any drugs, provide interpretive or diagnostic statements or provide for any life support. The Rhythm Express system communicates events from the patient to the monitoring center within one to seven minutes (assuming cell service is available) and hence is not suitable for use as a real-time arrhythmia event monitor.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K200833: RX-1 Rhythm Express Remote Cardiac Monitoring System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K200833

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026